dermavant.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-Agent: *
Meta Tags
Title Dermavant
Description Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® Dermavant Sciences is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics in
Keywords N/A
Server Information
WebSite dermavant favicondermavant.com
Host IP 162.159.134.42
Location United States
Related Websites
Site Rank
More to Explore
dermavant.com Valuation
US$20,489,463
Last updated: 2023-05-04 02:07:49

dermavant.com has Semrush global rank of 516,573. dermavant.com has an estimated worth of US$ 20,489,463, based on its estimated Ads revenue. dermavant.com receives approximately 2,364,169 unique visitors each day. Its web server is located in United States, with IP address 162.159.134.42. According to SiteAdvisor, dermavant.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$20,489,463
Daily Ads Revenue US$18,914
Monthly Ads Revenue US$567,401
Yearly Ads Revenue US$6,808,806
Daily Unique Visitors 157,612
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
dermavant.com. A 3599 IP: 162.159.134.42
dermavant.com. NS 86400 NS Record: ns6.dnsmadeeasy.com.
dermavant.com. NS 86400 NS Record: ns2.p10.dynect.net.
dermavant.com. NS 86400 NS Record: ns7.dnsmadeeasy.com.
dermavant.com. NS 86400 NS Record: ns4.p10.dynect.net.
dermavant.com. NS 86400 NS Record: ns1.p10.dynect.net.
dermavant.com. NS 86400 NS Record: ns3.p10.dynect.net.
dermavant.com. NS 86400 NS Record: ns5.dnsmadeeasy.com.
dermavant.com. MX 3600 MX Record: 0 us-smtp-inbound-1.mimecast.com.
dermavant.com. MX 3600 MX Record: 0 us-smtp-inbound-2.mimecast.com.
dermavant.com. TXT 3600 TXT Record: ZOOM_verify_AZEV0wZ4Qt-u7umzUzjJsg
dermavant.com. TXT 3600 TXT Record: v=spf1 mx ip4:149.72.161.246 ip4:149.72.190.43 ip4:149.72.227.21 ip4:167.89.111.77 ip4:168.245.22.106 ip4:168.245.23.37 ip4:168.245.61.128 ip4:168.245.125.167 ip4:216.146.32.161 ip4:216.146.32.188 ip4:216.146.32.187 ip4:216.146.32.186 ip4:216.146.32.185 ip4:81.93.173.201 ip4:81.93.164.103 ip4:69.169.229.106 ip4:69.169.229.107 ip4:69.169.229.110 ip4:69.169.229.111 ip4:69.169.229.112 ip4:69.169.229.113 ip4:69.169.229.114 ip4:69.169.229.115 include:_netblocks.mimecast.com include:servers.mcsv.net -all
dermavant.com. TXT 3600 TXT Record: atlassian-domain-verification=+6RQoqZNIkiBOw2mOmxo6t+XwDYXj7PrS8CucBHlHEdhymqJ7dX7p/fYZvVAsO/m
dermavant.com. TXT 3600 TXT Record: google-site-verification=aHMPfZlscyAr-KLoc77xsXv_xO5nTWaer4LxjigRR00
dermavant.com. TXT 3600 TXT Record: adobe-sign-verification=d4ad017abd91ff1fb95faeba9ea877c0
dermavant.com. TXT 3600 TXT Record: docusign=23bf72c0-f8ea-46c9-8f97-66397361c1ff
dermavant.com. TXT 3600 TXT Record: apple-domain-verification=G0xQFztdBhNyvALG
dermavant.com. TXT 3600 TXT Record: MS=ms84896754
dermavant.com. TXT 3600 TXT Record: 00930826
dermavant.com. TXT 3600 TXT Record: eia93ucdj1ifotvhsr06daham3
dermavant.com. TXT 3600 TXT Record: MS=ms36243269
dermavant.com. TXT 3600 TXT Record: 0ed1fe018ad8d32457660c4c15b02d9538df3de718
HtmlToTextCheckTime:2023-05-04 02:07:49
Patient Assistance Program Careers Contact Pipeline Leadership Management Team Board of Directors Medical Affairs MEDINFO Adverse Event Product Quality Complaint Research Focus Atopic Dermatitis Psoriasis Clinical Trials CME Grant Investigator Initiated Study Find your field medical director News & Investors Careers Contact Pipeline Leadership Medical Affairs News & Investors Careers Contact Management Team Board of Directors MEDINFO Adverse Event Product Quality Complaint Research Focus Clinical Trials CME Grant Investigator Initiated Study Find your field medical director Atopic Dermatitis Psoriasis March 15, 2023 Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA ® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old Read Press Release Mar 10, 2023 Dermavant to Present Data from Multiple Studies of VTAMA ® (tapinarof) cream, 1% at the 2023 American Academy of Dermatology Annual Meeting Read Press Release
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 26 Oct 2021 05:02:51 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://www.dermavant.com/
CF-Ray: 6a412280ce6e7f9c-ORD
CF-Cache-Status: DYNAMIC
ki-edge: v=16.4
X-Content-Type-Options: nosniff
X-Edge-Location-Klb: 1
Server: cloudflare
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Tue, 26 Oct 2021 05:02:51 GMT
content-type: text/html; charset=UTF-8
cf-ray: 6a41228269a8718f-ORD
link: ; rel="https://api.w.org/"
vary: Accept-Encoding
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
ki-edge: v=16.4
x-content-type-options: nosniff
x-edge-location-klb: 1
x-kinsta-cache: HIT
server: cloudflare
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
dermavant.com Whois Information
Domain Name: DERMAVANT.COM
Registry Domain ID: 261636328_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2019-08-29T04:19:54Z
Creation Date: 2005-11-20T18:40:31Z
Registry Expiry Date: 2021-11-20T18:40:31Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.P10.DYNECT.NET
Name Server: NS2.P10.DYNECT.NET
Name Server: NS3.P10.DYNECT.NET
Name Server: NS4.P10.DYNECT.NET
Name Server: NS5.DNSMADEEASY.COM
Name Server: NS6.DNSMADEEASY.COM
Name Server: NS7.DNSMADEEASY.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T06:06:00Z <<<

Copyright © 2022 WebZZ.US 0.0228